Role of the accessory gene regulator agr in community-associated methicillin-resistant Staphylococcus aureus pathogenesis

Infection and Immunity

Volumn 79, Issue 5, 2011, Pages 1927-1935

  Cheung, Gordon Y C ^a   Wang, Rong ^a,c   Khan, Burhan A ^a   Sturdevant, Daniel E ^b   Otto, Michael ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c U S MEAT ANIMAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGR PROTEIN; BACTERIAL PROTEIN; BINDING PROTEIN; FIBRINOGEN; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; GENE CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SKIN INFECTION; UPREGULATION;

ANIMALS; BACTERIAL PROTEINS; COMMUNITY-ACQUIRED INFECTIONS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MICE, NUDE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REGULON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAPHYLOCOCCAL SKIN INFECTIONS; TRANS-ACTIVATORS; VIRULENCE;

EID: 79955597012     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00046-11     Document Type: Article

References (49)

1. Baba, T., et al. 2002. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359:1819-1827.
2. Blevins, J. S., K. E. Beenken, M. O. Elasri, B. K. Hurlburt, and M. S. Smeltzer. 2002. Strain-dependent differences in the regulatory roles of sarA and agr in Staphylococcus aureus. Infect. Immun. 70:470-480.
3. Bokarewa, M. I., T. Jin, and A. Tarkowski. 2006. Staphylococcus aureus: staphylokinase. Int. J. Biochem. Cell Biol. 38:504-509.
4. Booth, M. C, et al. 1997. Staphylococcal accessory regulator (sar) in conjunction with agr contributes to Staphylococcus aureus virulence in endophthalmitis. Infect. Immun. 65:1550-1556.
5. Cassat, J. E., et al. 2005. Comparative genomics of Staphylococcus aureus musculoskeletal isolates. J. Bacteriol. 187:576-592.
6. CDC. 2003. Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections-Los Angeles County, California, 2002-2003. MMWR Morb. Mortal. Wkly. Rep. 52:88.
7. Cheng, A. G., et al. 2009. Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. FASEB J. 23:3393-3404.
8. Cheung, A. L., et al. 1994. Diminished virulence of a sar-/agr- mutant of Staphylococcus aureus in the rabbit model of endocarditis. J. Clin. Invest. 94:1815-1822.
9. Cheung, A. L., and S. J. Projan. 1994. Cloning and sequencing of sarA of Staphylococcus aureus, a gene required for the expression of agr. J. Bacteriol. 176:4168-4172.
10. Cheung, A. L., and G. Zhang. 2002. Global regulation of virulence determinants in Staphylococcus aureus by the SarA protein family. Front. Biosci. 7:d1825-d1842.
11. Clarke, S. R., and S. J. Foster. 2006. Surface adhesins of Staphylococcus aureus. Adv. Microb. Physiol. 51:187-224.
12. DeLeo, F. R., B. A. Diep, and M. Otto. 2009. Host defense and pathogenesis in Staphylococcus aureus infections. Infect. Dis. Clin. North Am. 23:17-34.
13. DeLeo, F. R., M. Otto, B. N. Kreiswirth, and H. F. Chambers. 2010. Community-associated meticillin-resistant Staphylococcus aureus. Lancet 375: 1557-1568.
14. Diep, B. A., et al. 2006. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367:731-739.
15. Diep, B. A., and M. Otto. 2008. The role of virulence determinants in community-associated MRSA pathogenesis. Trends Microbiol. 16:361-369.
16. Diep, B. A., et al. 2008. Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogen-esis. PLoS One 3:e3198.
17. Diep, B. A., et al. 2008. The arginine catabolic mobile element and staphy-lococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus au-reus. J. Infect. Dis. 197:1523-1530.
18. Foster, T. J. 2005. Immune evasion by staphylococci. Nat. Rev. Microbiol. 3:948-958.
19. Geisinger, E., R. P. Adhikari, R. Jin, H. F. Ross, and R. P. Novick. 2006. Inhibition of rot translation by RNAIII, a key feature of agr function. Mol. Microbiol. 61:1038-1048.
20. Giraudo, A. T., A. L. Cheung, and R. Nagel. 1997. The sae locus of Staphy-lococcus aureus controls exoprotein synthesis at the transcriptional level. Arch. Microbiol. 168:53-58.
21. Holden, M. T., et al. 2004. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc. Natl. Acad. Sci. U. S. A. 101:9786-9791.
22. Ji, G., R. Beavis, and R. P. Novick. 1997. Bacterial interference caused by autoinducing peptide variants. Science 276:2027-2030.
23. Kennedy, A. D., et al. 2010. Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J. Infect. Dis. 202:1050-1058.
24. Kennedy, A. D., et al. 2008. Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification. Proc. Natl. Acad. Sci. U. S. A. 105:1327-1332.
25. Klevens, R. M., et al. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763-1771.
26. Li, M., et al. 2007. The antimicrobial peptide-sensing system aps of Staphy-lococcus aureus. Mol. Microbiol. 66:1136-1147.
27. Li, M., et al. 2009. Evolution of virulence in epidemic community-associated MRSA. Proc. Natl. Acad. Sci. U. S. A. 106:5883-5888.
28. Li, M., et al. 2007. Gram-positive three-component antimicrobial peptide-sensing system. Proc. Natl. Acad. Sci. U. S. A. 104:9469-9474.
29. Montgomery, C. P., et al. 2008. Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. J. Infect. Dis. 198:561-570.
30. Moran, G. J., et al. 2006. Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355:666-674.
31. Novick, R. P. 2003. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol. Microbiol. 48:1429-1449.
32. Novick, R. P., et al. 1993. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J. 12:3967-3975.
33. Otto, M. 2010. Basis of virulence in community-associated methicillin-resis-tant Staphylococcus aureus. Annu. Rev. Microbiol. 64:143-162.
34. Park, J., et al. 2007. Infection control by antibody disruption of bacterial quorum sensing signaling. Chem. Biol. 14:1119-1127.
35. Queck, S. Y., et al. 2008. RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus. Mol. Cell 32:150-158.
36. Rice, K. C., and K. W. Bayles. 2003. Death's toolbox: examining the molecular components of bacterial programmed cell death. Mol. Microbiol. 50: 729-738.
37. Ruppitsch, W., et al. 2007. Occurrence of the USA300 community-acquired Staphylococcus aureus clone in Austria. Euro Surveill. 12:E071025.1.
38. Said-Salim, B., et al. 2003. Global regulation of Staphylococcus aureus genes by Rot. J. Bacteriol. 185:610-619.
39. Shibuya, Y., et al. 2008. Emergence of the community-acquired methicillin-resistant Staphylococcus aureus USA300 clone in Japan. J. Infect. Chemother. 14:439-441.
40. Tegmark, K., A. Karlsson, and S. Arvidson. 2000. Identification and characterization of SarH1, a new global regulator of virulence gene expression in Staphylococcus aureus. Mol. Microbiol. 37:398-409.
41. Thomas, J. B., F. W. Holtsberg, C. M. Ensor, J. S. Bomalaski, and M. A. Clark. 2002. Enzymic degradation of plasma arginine using arginine deiminase inhibits nitric oxide production and protects mice from the lethal effects of tumour necrosis factor alpha and endotoxin. Biochem. J. 363:581-587.
42. Vandenesch, F., et al. 2003. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg. Infect. Dis. 9:978-984.
43. Villaruz, A., et al. 2009. A point mutation in the agr locus rather than expression of the Panton-Valentine leukocidin caused previously reported phenotypes in Staphylococcus aureus pneumonia and gene regulation. J. Infect. Dis. 200:724-734.
44. Voyich, J. M., et al. 2006. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J. Infect. Dis. 194:1761-1770.
45. Wang, R., et al. 2007. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat. Med. 13:1510-1514.
46. Wardenburg, J. B., T. Bae, M. Otto, F. R. DeLeo, and O. Schneewind. 2007. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat. Med. 13:1405-1406.
47. Wardenburg, J. B., A. M. Palazzolo-Ballance, M. Otto, O. Schneewind, and F. R. Deleo. 2008. Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staph-ylococcus aureus disease. J. Infect. Dis. 198:1166-1170.
48. Witte, W., B. Strommenger, C. Cuny, D. Heuck, and U. Nuebel. 2007. Methicillin-resistant Staphylococcus aureus containing the Panton-Valentine leucocidin gene in Germany in 2005 and 2006. J. Antimicrob. Chemother. 60:1258-1263.
49. Wright, J. S., III, R. Jin, and R. P. Novick. 2005. Transient interference with staphylococcal quorum sensing blocks abscess formation. Proc. Natl. Acad. Sci. U. S. A. 102:1691-1696.